RO7046015, RO7046015, RO7046015 Placebo
BN42358
Phase 3 small_molecule active
Quick answer
RO7046015, RO7046015, RO7046015 Placebo for Early Parkinson's disease is a Phase 3 program (small_molecule) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Roche Registration Limited
- Indication
- Early Parkinson's disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active